8 IPOs Just Got SEBI’s Green Light: Your 2026 Investment Radar

While you were celebrating New Year, SEBI quietly approved 8 major IPOs worth thousands of crores. The window to get ahead of the crowd just opened—and it closes in 12-18 months.

Between December 26 and January 2, India’s market regulator cleared a diverse lineup that spans from fertility clinics to fitness equipment, signaling a robust start to 2025’s IPO season.

The Billion-Rupee Opportunity Nobody’s Talking About

RKCPL leads the pack with a whopping ₹1,250 crore infrastructure play, while EQT-backed Indira IVF eyes a ₹3,500 crore listing—making it potentially the year’s biggest healthcare debut.

But here’s the kicker: two companies filed through SEBI’s confidential route, giving them extra time (18 months vs 12) to launch. This strategic move suggests they’re timing the market carefully.

From Gym Equipment to Glass Walls: The Unusual Mix

Jerai Fitness brings cardiovascular equipment to public markets through a pure exit route—promoters cashing out while retail investors get in.

Glass Wall Systems offers facade solutions with a ₹60 crore fresh issue, backed by India Business Excellence Fund seeking exit.

Tempsens Instruments, a Rajasthan thermal engineering firm, plans ₹118 crore for expansion in electrical heating and specialized cables.

Read Also – Monday Market Alert: Venezuela Crisis + 5 Triggers

The Hidden Gems Worth Watching

Rays Of Belief (Mom’s Belief) – A child therapy organization going public. Unique healthcare play.

Chartered Speed – Gujarat’s passenger mobility company raising ₹855 crore (₹655 cr fresh + ₹200 cr OFS) to expand fleet and cut debt.

Shriram Food Industry – Maharashtra rice exporter mixing fresh shares with promoter exit.

5 Things Smart Investors Should Know Right Now

  1. Timeline matters: Companies have 12-18 months to launch—track their RHP filings
  2. Pure OFS deals (Jerai, Indira) mean zero dilution but full promoter exit
  3. Fresh issue IPOs fuel growth—watch fund utilization plans
  4. Sector diversity = hedged bets across infrastructure, healthcare, manufacturing
  5. EQT backing Indira IVF after withdrawing March filing shows refined strategy

Why This Matters to Your Portfolio

SEBI approvals are the official starting gun. These aren’t rumors or “may file soon” stories—these companies are legally cleared to tap public markets.

The confidential route filers (Indira IVF, Rays Of Belief) have extra flexibility, suggesting they’re waiting for optimal market conditions. That’s your cue to research now, not when the buzz starts.

The Bottom Line

Eight diverse companies, ₹7,000+ crore combined opportunity, 12-18 month launch window.

Your move: Bookmark this list. Watch for RHP filings. Read financials when they drop. The early bird doesn’t just get the worm—it gets the multibagger.

Which IPO intrigues you most? The fertility giant, the fitness disruptor, or the infrastructure play?


Share this with your investing group—someone’s looking for 2025’s hidden gems right now.

Investment Disclaimer (as per SEBI guidelines)

The information provided in this article is for educational and informational purposes only and should not be construed as investment advice, trading recommendation, or solicitation to buy or sell any securities, commodities, derivatives, or financial instruments.

Investments in the stock market and commodity markets (including gold and silver futures) are subject to market risks, including price volatility, liquidity risk, and regulatory risk. Past performance is not indicative of future results.

Readers are advised to conduct their own research and/or consult a SEBI-registered investment adviser, research analyst, or financial professional before making any investment or trading decisions. The author and publisher are not registered as SEBI investment advisers or research analysts, unless explicitly stated otherwise, and shall not be responsible for any financial losses incurred based on the information presented.

Commodity derivatives trading involves high leverage and risk of substantial loss and may not be suitable for all investors. Please carefully consider your financial situation, risk appetite, and investment objectives before participating.

SEBI Registration, if applicable, should be verified on the official SEBI website.

Source

Leave a Comment

Scroll to Top